Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RETICELL: Autologous Bone Marrow Stem Cells for Retinitis Pigmentosa
NCT01560715Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2011
- Primary completion
- Jan 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow stem cells in retinitis pigmentosa (RP), sponsored by Universidade de São Paulo. Primary endpoint: ETDRS Visual acuity change at 1 year. Started Jun 2011; status: completed.
02
Drugs
autologous bone marrow stem cells
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT01560715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560715.